All Type of News
NDM-1 to be designated as infectious disease
Starting in October, the government plans to control the multiple-drug resistant bacteria ‘NDM-1’ by designating it as “officially designated communicable disease” and running a surveillance system that receives a rea...
US Wholesalers seeking service fee
The major problem facing the Wholesale & Distribution industry in the United States is its low profit margin which is in the region of only 1-2%.
To cope with this unfavorable enviroment, three largest drug wholesa...
Peptron wins Australia patent for once-weekly anti-diabetic agent
Peptron Inc. says it recently won Australia patent for sustained release formulation of exenatide (codename: PT302). The firm won a Korean patent in February 2008.
Exenatide is the first and only approved incretin ...
BC World, CJ CheilJedang to co-market meropenem 1g in Korea
BC World Pharm and CJ CheilJedang will co-market meropenem 1g in the domestic market valued at 30 billion won, after holding a launching symposium on September 9.
Meropenem an ultra-broad spectrum injectable antibiot...
IFPW's biennial General Membership Meeting opens in Seoul
Hosted by the Korea Pharmaceutical Wholesalers Association (KPWA), the IFPW (International Federation of Pharmaceutical Wholesalers) General Membership Meeting opened at the Hotel Shilla Seoul, from Sept. 13 to 14, wi...
IFPW President emphasizes wholesalers’ role in pharmaceutical sector
Members in the International Federation of Pharmaceutical Wholesalers (IFPW) strive to provide companies with the insight needed to be successful in a changing marketplace and showcase the industry from the perspectiv...
KFDA to back small business policy
The Korea Food and Drug Administration (KFDA) will provide various policy incentives for small-and medium-sized enterprises (SMEs) in the local pharmaceutical sector.
In a recent meeting with CEOs of 10 pharmaceuti...
KFDA to get tough over narcotics validation
The KFDA says that method validation on narcotics should be made available on three consecutive batches to ensure better quality, even though narcotics manufacturers said such validation rules are quite burdensome in ...
Neuronex’s NXCL-4950 wins global technology award
Neuronex Co., a Korean biopharmaceutical co company, says its peripheral blood vessel vasodilator ‘NXCL-4950’ received a special technology award in the 10th Moscow International Salon of Innovations and Investments, ...
Korea health insurance to suffer 22 trillion won in deficit in 2030
The National Health Insurance will see about 22 trillion won in deficit in 2030, considering the number of ever-growing Koreans aged over 65, according to the Korea Institute for Health and Social Affairs (KIHASA).
...
